Bioven is under clinical development by Biopharma Plasma and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia. According to GlobalData, Phase III drugs for Coronavirus Disease ...

Successfully dosed 6 patients in safety run-in segment, now accelerating enrollmentPositive data from first four patients announced December ...

After hours: January 17 at 5:13:17 PM EST Loading Chart for BNTC ...

Quantum BioPharma will become available Tuesday, January 14 at 10:00am EST under the ticker symbol ‘QNTM‘ on Upstream, a MERJ Exchange market and global securities trading app. The dual ...

After hours: January 17 at 4:09:09 PM EST Loading Chart for CUE ...

GC Biopharma manufactured its first plasma-derived therapy in South Korea in 1971. Since then, the company has grown to become one of the top pharmaceutical manufacturers of plasma therapeutics in ...

Roche Holding AG Akt 0.67% CHF207.07B ...

SEC Filings provided by EDGAR Online, Inc.

In the race to bolster pipelines and drive growth, biopharma manufacturers are reexamining traditional practices and reimagining market research protocols. Biopharma business development and licensing ...